Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Ltd has informed BSE that a Board of Directors meeting is scheduled for November 14, 2025 at 6:00 PM. The meeting will consider and approve the unaudited financial results for the half year ended September 30, 2025, along with noting the limited review report from statutory auditors. The trading window for designated persons under the Insider Trading Policy remains closed from October 1, 2025 to November 16, 2025. The company's scrip code on BSE is 540729.
This is a routine regulatory intimation with no direct impact on shareholders. Investors should watch for the actual results announcement on or after November 14, 2025 to assess the company's half-yearly performance.